Fennec Pharmaceuticals (FENC) Assets Average (2011 - 2025)

Fennec Pharmaceuticals (FENC) has 15 years of Assets Average data on file, last reported at $59.9 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 15.35% year-over-year to $59.9 million; the trailing twelve-month figure through Dec 2025 stood at $59.9 million (up 15.35% YoY), and the FY2025 full-year result was $57.7 million, up 60.84% from the prior year.
• Assets Average for Q4 2025 stood at $59.9 million, up from $47.1 million in the prior quarter.
• Across five years, Assets Average topped out at $66.2 million in Q2 2024 and bottomed at $17.4 million in Q2 2022.
• The 5-year median for Assets Average is $28.3 million (2021), against an average of $35.6 million.
• The widest annual swing landed in 2022, when Assets Average sank 37.94%; it then soared 220.8% in 2024.
• A 5-year view of Assets Average shows it stood at $24.2 million in 2021, then climbed by 18.44% to $28.7 million in 2022, then fell by 18.33% to $23.4 million in 2023, then jumped by 121.74% to $51.9 million in 2024, then rose by 15.35% to $59.9 million in 2025.
• The last three Assets Average figures came in at $59.9 million (Q4 2025), $47.1 million (Q3 2025), and $45.6 million (Q2 2025), per Business Quant data.

Peer Comparison